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The cri-du-chat syndrome is caused by a deletion on the short 
arm of chromosome number 5. The size of genetic material loss 
varies from the 5p15.2 region only to the whole arm. Prevalence 
rates range between 1:15000 and 1:50000 live births. Diagnosis 
is suspected on infants with a high-pitched (cat-like) cry, facial 
dysmorfism, hypotonia and delayed psychomotor development. 
In adults, phenotypic findings are less specific. It is confirmed 
through high-resolution G-banding karyotype, fluorescent in 
situ hybridization or microarray-based comparative genomic 
hybridization (a-CGH).
The following is the case report of a 21-year-old female patient 
with severe mental retardation and trichotillomania, who does 
not control sphincters and does not bathe or eat by herself. Her 
communication is based only on sounds and dysmorphic facies. 
The G-band karyotype reported is 46, XX. a-CGH shows 18.583Mb 
interstitial microdeletion in 5p15.33p14.3, including the cri-du-
chat critical region. In children or adults with unexplained mental 
retardation and normal karyotype results (like this case), an a-CGH 
should be performed to make an etiological diagnosis, establish the 
prognosis, order additional medical tests and specific treatments, and 
offer appropriate genetic counseling. 
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| Resumen |
El síndrome de cri du chat o del maullido de gato es causado por una 
deleción en el brazo corto del cromosoma 5; el tamaño de la pérdida 
de material genético varía desde solo la región 5p15.2 hasta el brazo 
entero. La prevalencia va desde 1 por 15 000 habitantes hasta 1 por 
50 000 habitantes. Su diagnóstico se puede confirmar con cariotipo 
con bandas G de alta resolución, hibridación fluorescente in situ o 
hibridación genómica comparativa por microarreglos (HGCm); este 
se sospecha en infantes con un llanto similar al maullido de un gato, 
fascies dismórficas, hipotonía y retardo del desarrollo psicomotor; 
sin embargo, en los adultos afectados los hallazgos fenotípicos son 
menos específicos. 
Se presenta el caso de una mujer de 21 años con retardo mental 
severo y tricotilomanía, que no controla esfínteres y no se baña ni 
come sola; solo emite ruidos y tiene facies dismórficas. El cariotipo 
de bandas G es reportado 46, XX y la HGCm muestra microdeleción 
de 18.583Mb en 5p15.33p14.3, incluyendo región crítica de cri du 
chat. En pacientes de este tipo se debe realizar HGCm para hacer 
un diagnóstico etiológico, establecer un pronóstico, ordenar pruebas 
médicas adicionales y tratamientos específicos y realizar la adecuada 
asesoría genética. 
Palabras clave: Síndrome del maullido del gato; Síndrome de 
deleción del brazo corto del cromosoma 5; hibridación genómica 
comparativa; Discapacidad intelectual (DeCS).
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Introduction
The cri-du-chat syndrome (CdCS) or cat meowing is a disease caused 
by a deletion in the short arm of chromosome 5. The size of the 
genetic material loss varies and ranges between the whole arm and 
the 5p15.2 region only. This syndrome affects from 1 in 15 000 to 1 
in 50 000 inhabitants (1,2).
A CdCS diagnosis is suspected in infants with acute crying, similar 
to a cat’s meow; size and weight less than two standard deviations; 
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hypotonia; psychomotor development delay, and particular facies 
characterized by rounded face, hypertelorism, broad nasal bridge, 
epicantic folds, micrognathia and ears with low implantation (3). 
The disease is confirmed through cytogenetic techniques such 
as karyotype by light microscopy with high-resolution G-bands. 
Hybridization fluorescence in situ (HFIS) should be performed as the 
first molecular cytogenetic test, with a specific probe that includes 
the 5p15.2 (4,5) region, for those who have a suggestive phenotype 
and unaltered karyotype. 
In order to find the etiology in patients with unexplained mental 
retardation and nonspecific phenotypic findings —for instance, 
adult patients with CdCS characteristics—, comparative genomic 
hybridization by microarrays (a-CGH) has been suggested, which 
is a different molecular cytogenetic test. This test examines the 
entire genome and can find numerical and structural chromosomal 
alterations similar to those diagnosed by the karyotype, while 
detecting losses or excesses of genetic material with a higher 
resolution level than that diagnosed by conventional cytogenetic 
techniques (6).
The objective of this report is to present the case of a 21-year-old 
patient with severe mental retardation of unexplained origin and a 
karyotype that did not show any cytogenetic alteration. The a-CGH 
for this patient reported a microdeletion in 5p15.33 p14.3, which 
served as the basis for a CdCS diagnosis.
Case report
21-year-old female patient born to non-consanguineous parents. The 
patient’s mother got pregnant at age 23, and had adequate prenatal care 
with two obstetrical ultrasounds that did not detect any abnormality. 
The patient was delivered via cesarean section due to post-term 
pregnancy and acute fetal distress. The newborn was hospitalized 
for 10 days due to poor suction.
The patient has poor psychomotor development, and has not 
received any type of education due to learning and aggression problems. 
In addition, by the time of the assessment, she was unable to speak 
—she only produces noises—. Sphincters are not controlled, she does 
not bathe or eat by herself and presents with trichotillomania. Auditory 
potentials show mild bilateral hypoacusis and no abnormalities on the 
echocardiogram. A karyotype with G-bands with a resolution level 
of 550 bands (as reported by the laboratory) was performed at age 1, 
showing the chromosomal formula 46, XX. 
Physical examination showed the following special findings: 
dysmorphic fasciitis due to bitemporal depression, right epicanthic 
fold, large nose with broad nasal bridge, microretrognathia, 
persistently large open mouth, macroglossia, short subnasal philtrum, 
and single transverse palmar crease (Figure 1). a-CGH and nuclear 
magnetic resonance were requested, but were not performed because 
the patient offered resistance during the procedure.
Figure 1. Patient with cri-du-chat syndrome.  
Source: Own elaboration based on the data obtained in the study.
The genetic test was performed by extracting 10mL of peripheral 
blood in two tubes, one with sodium-heparin and another with 
ethylenediaminetetraacetic acid, which were subsequently sent to 
the Medical Genetics Laboratory of the Baylor College of Medicine. 
DNA was extracted using an automated nucleic acid extraction 
instrument (PerkinElmer Chemagen Technologie GmbH), which 
allows obtaining genetic material. A high-resolution chromosomal 
microarray analysis (HR-CMA) was performed using 180 000 
oligos covering the whole genome at an average resolution of 30Kb. 
Sample and control DNA were differentially labeled with 
fluorescence and were hybridized with the oligos. The a-CGH matrices 
used to analyze chromosome 5p were built by Agilent Technologies, 
which are based on the platform designed by the laboratory (BMGL 
V8.1.1). During the DNA study, the “Vysis Cri-du-Chat-Region Probe-
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LSI D5S23” probe was labeled with green fluorochrome, and the “Vysis 
LSI EGR1” was used for control and labeled with orange fluorochrome. 
Results were analyzed using quantitative imaging methods and 
analytical software to identify the DNA sequences studied, as well as 
the loss (deletion), gain (duplication) or normality in the copies based 
on the presence or absence of signals for the D5S23 and EGR1 probes.
The patient’s a-CGH result showed abnormal interstitial 
microdeletion of 18 583MB in the short arm of chromosome 5, 
5p15.33p14.3, which includes the cri-du-chat critical region. Figure 
2 shows a red area that identifies DNA in deletion and includes the 
CdCS critical region. The black spots represent chromosomes without 
an excess or deficit of genetic material.
Figure 2. Graphical representation of the result for comparative genomic hybridization by microarray.  
Source: Own elaboration based on the data obtained in the study. 
A diagnosis of cri-du-chat syndrome by microdeletion, OMIM 
# 123450, was established. Since the patient’s mother had a tubal 
ligation and the father had no reproductive expectation, no tests were 
performed to establish if any of them were carriers of a balanced 
translocation involving the chromosomal region under study. Both 
parents signed an informed consent to take photographs and use the 
medical history data. 
Discussion
Lejeune et al. (7) first described CdCS in 1963. They gave the 
syndrome this name due to the characteristic cry of affected infants, 
which resembles a meowing kitten. The prevalence is very low, 
although it is estimated at 1 for every 350 individuals with mental 
retardation (1,2,8). This syndrome is caused by a deletion of the short 
arm of chromosome 5, which can involve total loss of the material 
on the short arm, or affect only the 5p15.2 region (9).
In CdCS, the loss of genetic material in a specific locus of the 
short arm of chromosome 5 has been related to particular phenotypic 
traits in affected patients. Likewise, a critical region located at 5p15.2, 
1.7MB in size and strongly related to mental retardation, language 
delay, typical crying, microcephaly and dysmorphic fascicles has 
been described (8,10). Deletion in that region implies the loss of 
the CTNND2 genes, which encode the δ-catenin protein, and of 
MARCH6, which encodes the protein of the same name (membrane-
associated RING-CH6 finger protein). The first is involved in cell 
motility, expressed in the early stages of neuronal development, 
especially in cellular migration processes, which is related to the 
characteristic mental retardation. The second is an E3 ubiquitin-ligase 
located in the membranes of the endoplasmic reticulum, which has 
been associated with typical acute crying, language problems and 
facial features in CdCS (11).
In addition, other genes with 5p loci and clinical significance in 
CdCS have been reported. SEMA5A (locus 5p15.31) encodes the 
semaphorin 5A protein associated with mental retardation caused by 
the reduction in the number of neurons to be differentiated, and to 
the migration from neurogenesis zones, which generates changes in 
the organization of the periventricular cortex layers and base ganglia 
(9).  SLC6A3 (locus 5p15.33) encodes a dopamine transporter and is 
linked to attention deficit hyperactivity disorder and autistic features. 
CDH18, CDH12, CDH10 and CDH9 (locus 5p14.1 to 5p14.3) 
encode critical cadherins in cell adhesion during synapse formation 
and axonal growth. Finally, TERT (locus 5p15.33) produces reverse 
transcriptase associated with accelerated shortening of telomeres and 
premature aging (11,12).
In 2005, Zhang et al. (13) published a phenotype/genotype 
correlation study using microarray-based comparative genomic 
hybridization. They described three contiguous regions on the short 
arm of chromosome 5 called MR (referring to mental retardation): 
region I with locus 5p15. 31, size 1.2MB, related to moderate to 
severe mental retardation; region II, proximal to region I, size 8.9MB, 
associated to less severe mental retardation, and region III, proximal 
to region II, 13.8MB and without a consistent phenotype. Mental 
retardation increases progressively with the joint loss of the described 
regions, and the critical region would include MRI. In addition, the 
same authors specifically associated crying to the 5p15.31 region, 
language delay to the 5p15.32-15.33 region, and dysmorphic features 
to the 5p15.2-15.31 region (8,11,13). The loss of genetic material in 
this patient was located in the 5p15.33 p14.3 region, which includes all 
fragments of genetic material related to the pathological phenotype in 
CdCS. This loss accounts for severe mental retardation, microcephaly, 
and marked language deficit. 
Between 80% and 90% of the deletions that cause CdCS are de 
novo, about 10% to 15% are the result of unbalanced translocations of 
parental, and some particular cases are attributed to rare cytogenetic 
alterations (1). The risk of recurrence is minimal in cases in which the 
deletion is de novo; however, the possibility of gonadal mosaicism 
in one of the parents cannot be disregarded. The probability is higher 
and becomes more important in familial balanced translocation cases 
that include the 5p fragment. Cerruti et al. (14) show that the risk 
of progeny with unbalanced chromosome alteration ranges between 
8.7% and 18.8%, and that it is similar in carriers of both sexes. In cases 
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such as the one reported here, a balanced translocation in parents that 
included the missing 5p fragment in the patient (5p15.33p14.3) should 
be ruled out through a metaphase HFIS using the specific probe. 
CdCS patients may present with typical crying, short stature and 
weight, severe psychomotor development delay, hypotonia, particular 
facies (4,8), recurrent vomiting, respiratory difficulties, severe heart 
disease and jaundice, which can lead to death within the first year 
of life (15), although none of them was found in the treated patient. 
As patients grow, the face becomes long, thin and asymmetrical, 
the nose becomes more prominent, and hypertelorism, epicanto and 
micrognathia are attenuated. Mental retardation becomes evident 
in preadolescents and adolescents, who usually do not speak and 
present periods of aggressive behavior and self-mutilation (9,15); 
all these characteristics were observed in the treated patient. Over 
time, the phenotypic traits in these patients become less specific 
and clinical diagnosis is more difficult (16). A differential diagnosis 
in adult patients without changes in karyotype can be performed 
based on the Mowat-Wilson and Wolf-Hirschhorn syndromes, 1p36 
monosomy, 17q21 microdeletion, among others. 
Usually, the diagnosis is suspected when the classic phenotypic 
characteristics appear in children younger than one year. To confirm 
it, a karyotype with G-bands must be performed, which, depending 
on the resolution level, can detect the total or partial absence of 
genetic material in the short arm of chromosome 5 (17). However, 
the diagnostic capacity of the karyotype in structural chromosomal 
alterations, such as CdCS, varies depending on whether the 
chromosomes are observed in prometaphase or metaphase, the type of 
staining and the level of resolution obtained according to the observed 
bands. In metaphase karyotypes with Giemsa staining (G-bands) and 
resolution levels between 400 and 500 bands, alterations greater than 
10MB can be detected. The diagnostic capacity improves when the 
chromosomes are observed in prometaphase, which lead to diagnose 
losses or excesses of genetic material greater than 3MB (18). 
The karyotype of the treated patient was performed with metaphase 
chromosomes, had a resolution of 550 bands and did not report 
any numerical or structural alterations despite having a deletion of 
18MB in 5p that should have been found in that study. This may 
have happened because chromosome analysis by cytogenetics is 
a dependent operator, which does not occur with a-CGH, and has 
limitations in the resolution level due to difficulties in the visualization 
of specific areas considering the characteristics of the staining (18). 
Hence, the level of bands reached on chromosome 5 may not be 
optimal for the diagnosis. 
In cases where the karyotype does not show any alteration and the 
phenotypic characteristics are suggestive, HFIS must be performed 
using probes that detect losses of fragments of different sizes in the 
short arm of chromosome 5, including the 5p13 to p15 regions; the 
most used is the one that hybridizes with the CdCS 5p15.2 critical 
region (5). In the case reported here, the karyotype was not repeated 
and the HFIS was not used, since this was an adult patient with no 
specific phenotype.
A-CGH has been suggested to find the specific etiology in patients 
with mental retardation, autism and multiple congenital anomalies 
(6); this is a molecular test that detects losses or excess of genetic 
material smaller than those diagnosed with cytogenetic techniques by 
light microscopy. However, it is not sensitive to detect chromosomal 
rearrangements such as balanced translocations or specify insertion 
location (19). Diagnosis rates in patients with delayed psychomotor 
development and mental retardation increased from 3% with 
karyotype to 12.2% with a-CGH (6).
Comparative genomic hybridization is available in Colombia 
and is performed in two laboratories of Bogotá D.C. or in reference 
laboratories from Europe and the USA, as was the case with this 
patient. The importance of the test lies in obtaining a diagnosis and 
thus establishing prognosis and ordering additional medical tests and 
treatments specific to the syndrome, besides offering genetic and 
reproductive advice (4,14,19). 
Conclusions
The case of a 21-year-old female patient was reported in this paper. 
The patient presented with severe mental retardation of unexplained 
origin, with unchanged karyotype, and a-CGH with microdeletion in 
5p15.33 p14.3, which led to the CdCS diagnosis.
A-CGH should be performed in adult patients with unexplained 
mental retardation with karyotype and without alteration, in order 
to obtain an etiological diagnosis, establish prognosis and perform 
differentiated interventions and genetic counseling. 
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